1. Fjell CD, Hancock RE, Cherkasov A. AMPer: Adatabase and an automated
discovery tool for antimicrobial peptides. Bioinformatics 2007;23:1148-55.
2. Wang G, Li X, Wang Z. APD2: The updated antimicrobial peptide database
and its application in peptide design. Nucleic Acids Res 2009;37:D933-7.
3. Boman HG. Antimicrobial peptides: Basic facts and emerging concepts.
J Intern Med 2003;254:197-215.
4. van’t Hof W, Veerman E, Helmerhorst E, Amerongen AV. Antimicrobial
peptides: Properties and applicability. Biol Chem 2001;382:597-619.
5. McDermott AM. Defensins and other antimicrobial peptides at the ocular
surface. Ocul Surf 2004;2:229-47.
6. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity.
J Leukoc Biol 2004;75:39-48.
7. Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat Rev
Immunol 2003;3:710-20.
8. Lehrer RI. Primate defensins. Nat Rev Microbiol 2004;2:727-38.
9. Bals R. Epithelial peptides in host defense against infection. Respir Res
2000;1:141-50.
10. Eckmann L. Defence molecules in intestinal innate immunity against
bacterial infections. Curr Opin Gastroenterol 2005;21:147-51.
11. Zanetti M, Gennaro R, Romeo D. Cathelicidins: A novel protein family with
a common proregion and a variable C-terminal antimicrobial domain. FEBS
Lett 1995;374:1-5.
12. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. Structure
and organization of the human antimicrobial peptide LL-37 in phospholipid
membranes: Relevance to the molecular basis for its non-cell-selective
activity. Biochem J 1999;341:501-13.
13. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman H, Gudmundsson G.
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed
in bone marrow and testis. Proc Natl Acad Sci U S A 1995;92:195-9.
14. De Smet K, Contreras R. Human antimicrobial peptides: Defensins,
cathelicidins and histatins. Biotechnol Lett 2005;27:1337-47.
15. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18:
A novel antimicrobial lipopolysaccharide-binding protein. Infect Immun
1995;63:1291-7.
16. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B,
Salcedo R. The human gene FALL-39 and processing of the cathelin
precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem
1996;238:325-32.
17. Cowland JB, Johnsen AH, Borregaad N. hCAP-18, a cathelin/probactenecinlike protein of human neutrophil specific granules. FEBS Lett 1995;368:173-6.
18. Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18
is expressed in epithelia of the human lung where it has broad antimicrobial
activity at the airway surface. Proc Natl Acad Sci U S A 1998;95:9541-6.
19. Frohm M, Agerberth B, Ahangari G, Stâhle-Bäckdahl M, Lidén S, Wigzell H,et al. The expression of the gene coding for the antimicrobial peptide LL-37
is induced in human keratinocytes during inflammatory disorders. J Biol
Chem 1997;272:15258-63.
20. Nilsson MF, Sandstedt B, Sorensen O, Weber G, Borregaard N, StåhleBäckdahl M. The human cationic antimicrobial protein (hCAP18), a peptide
antibiotic, is widely expressed in human squamous epithelia and colocalizes
with interleukin-6. Infect Immun 1999;67:2561-6.
21. Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member
of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta
2006;1758:1408-25.
22. Schaller-Bals S, Schulze A, Bals R. Increased levels of antimicrobial
peptides in tracheal aspirates of newborn infants during infection. Am J
Respir Crit Care Med 2002;165:992-5.
23. Malm J, Sorensen O, Persson T, Frohm-Nilsson M, Johansson B, Bjartell A,
et al. The human cationic antimicrobial protein (hCAP-18) is expressed
in the epithelium of human epididymis, is present in seminal plasma
at high concentrations, and is attached to spermatozoa. Infect Immun
2000;68:4297-302.
24. Méndez-Samperio P. The human cathelicidin hCAP18/LL-37:
A multifunctional peptide involved in mycobacterial infections. Peptides
2010;31:1791-8.
25. Yang CS, Shin DM, Kim KM, Lee ZW, Lee CH, Park SG, et al. NADPH
oxidase 2 interaction with TLR2 is required for efficient innate immune
responses to mycobacteria via cathelicidin expression. J Immunol
2009;182:3696-705.
26. Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ,
Chertov O, et al. The structure of human beta-defensin-2 shows evidence
of higher order oligomerization. J Biol Chem 2000;275:32911-8.
27. Lehrer R, Lichtenstein A, Ganz T. Defensins: Antimicrobial and cytotoxic
peptides of mammalian cells. Annu Rev Immunol 1993;11:105-28.
28. Ganz T, Lehrer RI. Defensins. Pharmacol Ther 1995;66:191-205.
29. García JR, Krause A, Schulz S, Rodríguez-Jiménez FJ, Klüver E,
Adermann K, et al. Human b-defensin 4: A novel inducible peptide with
a specific salt-sensitive spectrum of antimicrobial activity. FASEB J
2001;10:1819-21.
30. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zassloff M. Human
b-defensin-1 is a salt-sensitive antibiotic in the lung that is inactivated in
cystic fibrosis. Cell 1997;88:553-60.
31. Rodriguez-Jimenez FJ, Krause A, Schulz S, Forssmann WG, ConejoGarcia JR, Schreeb R, et al. Distribution of new human beta-defensin
genes clustered on chromosome 20 in functionally different segments of
epididymis. Genomics 2003;81:175-83.
32. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ,
et al. Discovery of five conserved beta-defensin gene clusters using a
computational search strategy. Proc Natl Acad Sci U S A 2002;99:2129-33.
33. Schutte BC, McCray PB. Beta-defensins in lung host defense. Annu Rev
Physiol 2002;64:709-48.
34. Sparkes RS, Kronenberg M, Heinzmann C, Daher KA, Klisak I, Ganz T, et al.
Assignment of defensin gene(s) to human chromosome 8p23. Genomics
1989;5:240-4.
35. Linzmeier R, Michaelson D, Liu L, Ganz T. The structure of neutrophil
defensin genes. FEBS Lett 1993;321:267-73.
36. Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL. Tracheal
antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal
mucosa:peptide isolation and cloning of a cDNA. Proc Natl Acad Sci U S
A 1991;88:3952-6.
37. Bensch K, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG. HBD-1:
A novel b-defensin from human plasma. FEBS Lett 1995;368:331-5.
38. Harder J, Bartels J, Christophers E, Schröder JM. A peptide antibiotic from
human skin. Nature 1997;387:861.
39. Schröder JM, Harder J. Human beta-defensin-2. Int J Biochem Cell Biol
1999;31:645-51.
40. Méndez-Samperio P, Miranda E, Trejo A. Mycobacterium bovis Bacillus
Calmette-Guérin (BCG) stimulates human beta-defensin-2 gene
transcription in human epithelial cells. Cell Immunol 2006;239:61-6.
41. Harder J, Bartels J, Christophers E, Schröder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide
antibiotic. J Biol Chem 2001;276:5707-13.
42. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. Multiple roles
of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin
in host defense. Annu Rev Immunol 2004;22:181-215.
43. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC,
et al. The cationic antimicrobial peptide LL-37 Modulates dendritic cell
differentiation and dendritic cell induced T cell polarization. J Immunol
2004;172:1146-56.
44. Braff MH, Hawkins MA, Di Nardo A, Lopez-Garcia B, Howell MD, Wong C,
et al. Structure–function relationships among human cathelicidin peptides:
Dissociation of antimicrobial properties from host immunostimulatory
activities. J Immunol 2005;174:4271-8.
45. Agerberth B, Gudmundsson GH. Host antimicrobial defence peptides in
human disease. Curr Top Microbiol Immunol 2006;306:67-90.
46. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE. The human
antimicrobial peptide LL-37 is a multifunctional modulator of innate immune
responses. J Immunol 2002;169:3883-91.
47. Bowdish DM, Davidson DJ, Hancock RE. A re-evaluation of the role of
host defence peptides in mammalian immunity. Curr Protein Pept Sci
2005;6:35-51.
48. Hase K, Murakami M, Iimura M, Cole SP, Horibe Y, Ohtake T, et al.
Expression of LL-37 by human gastric epithelial cells as a potential
host defense mechanism against Helicobacter pylori. Gastroenterology
2003;125:1613-25.
49. Woo JS, Jeong JY, Hwang YJ, Chae SW, Hwang SJ, Lee HM. Expression
of cathelicidin in human salivary glands. Arch Otolaryngol Head Neck Surg
2003;129:211-4.
50. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H,
et al. A cathelicidin family of human antibacterial peptide LL-37 induces
mast cell chemotaxis. Immunology 2002;106:20-6.
51. Niyonsaba F, Ogawa H. Protective roles of the skin against infection:
Implication of naturally occurring human antimicrobial agents betadefensins, cathelicidin LL-37 and lysozyme. J Dermatol Sci 2005;40:157-68.
52. Soehnlein O, Zernecke A, Eriksson E, Rothfuchs AG, Pham CT, Herwald H,
et al. Neutrophil secretion products pave the way for inflammatory
monocytes. Blood 2008;112:1461-71.
53. Chaly YV, Paleolog EM, Kolesnikova TS, Tikhonov I, Petratchenko EV,
Voitenok N. Neutrophil alpha-defensin human neutrophil peptide modulates
cytokine production in human monocytes and adhesion molecule expression
in endothelial cells. Eur Cytokine Netw 2000;11:257-66.
54. Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms
by antimicrobial peptides. J Invest Dermatol 2005;125:9-13.
55. Syeda F, Tullis E, Slutsky AS, Zhang H. Human neutrophil peptides
upregulate expression of COX-2 and endothelin-1 by inducing oxidative
stress. Am J Physiol Heart Circ Physiol 2008;294:H2769-74.
56. Schmid P, Grenet O, Medina J, Chibout SD, Osborne C, Cox DA. An
intrinsic antibiotic mechanismin wounds and tissue-engineered skin. J Invest
Dermatol 2001;116:471-2.
57. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al.
Beta-defensins: Linking innate and adaptive immunity through dendritic
and T cell CCR6. Science 1999;286:525-8.
58. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K,
et al. Antimicrobial peptides human beta-defensins stimulate epidermal
keratinocyte migration, proliferation and production of proinflammatory
cytokines and chemokines. J Invest Dermatol 2007;127:594-604.
59. Nagaoka I, Niyonsaba F, Tsutsumi-Ishii Y, Tamura H, Hirata M. Evaluation
of the effect of human beta-defensins on neutrophil apoptosis. Int Immunol
2006;20:543-53.
60. Baroni A, Donnarumma G, Paoletti I, Longanesi-Cattani I, Bifulco K,
TufanoMA, et al. Antimicrobial human beta defensin-2 stimulates migration,
proliferation and tube formation of human umbilical vein endothelial cells.
Peptides 2009;30:267-72.
61. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, et al.
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial
peptide. Nature 2007;449:564-9.62. Lai Y, Gallo RL. AMPed up immunity: How antimicrobial peptides have
multiple roles in immune defense. Trends Immunol 2009;30:131-41.
63. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D,
et al. Psoriasis is associated with increased beta-defensin genomic copy
number. Nat Genet 2008;40:23-5.
64. Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A,
et al. Increased serine protease activity and cathelicidin promotes skin
inflammation in rosácea. Nat Med 2007;13:975-80.
65. Di Nardo A, Braff MH, Taylor KR, Na C, Granstein RD, McInturff JE, et al.
Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and
allergic contact sensitization. J Immunol 2007;178:1829-34.
66. Marta Guarna M, Coulson R, Rubinchik E. Anti-inflammatory activity of
cationic peptides: Application to the treatment of acne vulguris. FEMS
Microbiol Lett 2006;257:1-6.
67. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T,
et al. Endogenous antimicrobial peptides and skin infections in atopic
dermatitis. N Engl J Med 2002;347:1151-60.
68. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J,
Bevins CL, et al. A chromosome 8 gene-cluster polymorphism with low
human beta-defensin 2 gene copy number predisposes to Crohn disease
of the colon. Am J Hum Genet 2006;79:439-48.
69. Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR,
Fellermann K, et al. Inducible and constitutive beta-defensins are
differentially expressed in Crohn’s disease and ulcerative colitis. Inflamm
Bowel Dis 2003;9:215-23.
70. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. BetaDefensin-3 and -4 in intestinal epithelial cells display increased mRNA
expression in ulcerative colitis. Clin Exp Immunol 2004;137:379-85.
71. Wehkamp J, Wang G, Kubler I, Nuding S, Gregorieff A, Schnabel A,
et al. The Paneth cell alpha-defensin deficiency of ileal Crohn’s disease is
linked to Wnt ⁄ Tcf-4. J Immunol 2007;179:3109-18.
72. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, et al.
Innate antimicrobial peptide protects the skin from invasive bacterial
infection. Nature 2001;414:454-7.
73. Dorschner RA, Lin KH, Murakami M, Gallo RL. Neonatal skin in mice
and humans expresses increased levels of antimicrobial peptides: Innate
immunity during development of the adaptive response. Pediatr Res
2003;53:566-72.
74. Murakami M, Ohtake T, Dorschner RA, Schittek B, Garbe C, Gallo RL.
Cathelicidin nti-microbial peptide expression in sweat, an innate defense
system for the skin. J Invest Dermatol 2002;119:1090-5.75. Sayama K, Komatsuzawa H, Yamasaki K, Shirakata Y, Hanakawa Y,
Ouhara K, et al. New mechanisms of skin innate immunity: ASK1-mediated
keratinocyte differentiation regulates the expression of beta-defensins,
LL37, and TLR2. Eur J Immunol 2005;35:1886-95.
76. Miles K, Clarke DJ, Lu W, Sibinska Z, Beaumont PE, Davidson DJ,
et al. Dying and necrotic neutrophils are anti-inflammatory secondary to the
release of alpha-defensins. J Immunol 2009;183:2122-32.
77. Ryan L, Diamond G. Mouse beta-defensin-1 plays a role in influenza innate
immunity. J Immunol 2010;184:37-49.
78. Sharma KR, Reddy PR, Tegge W, Jain R. Discovery of Trp-His and His-Arg
analogues as new structural classes of short antimicrobial peptides. J Med
Chem 2009;52:7421-31.
79. Rodziewicz-Motowidlo S, Mickiewicz B, Greber K, Sikorska E,
Szultka L, Kamysz E, et al. Antimicrobial and conformational studies of
the active and inactive analogues of the protegrin-1 peptide. FEBS J
2010;277:1010-22.
80. Saviello RM, Malfi S, Campiglia P, Cavalli A, Grieco P, Novellino E, et al.
A New insight into the mechanism of action of the temporin antimicrobial
peptides. Biochemistry 2010;49:1477-85.
81. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, et al. Administration
of oral vitamin D induces cathelicidin production in atopic individuals.
J Allergy Clin Immunol 2008;122:829-31.
82. Segaert S. Vitamin D regulation of cathelicidin in the skin: Toward
a renaissance of vitamin D in dermatology? J Invest Dermatol
2008;128:773-5.
83. Schwab M, Reynders V, Shastri Y, Loitsch S, Stein J, Schröder O. Role
of nuclear hormone receptors in butyrate-mediated up-regulation of the
antimicrobial peptide cathelicidin in epithelial colorectal cells. Mol Immunol
2007;44:2107-14.
84. Jacobsen F, Mittler D, Hirsch T, Gerhards A, Lehnhardt M, Voss B, et al.
Transient cutaneous adenoviral gene therapy with human host defense
peptide hCAP-18/LL-37 is effective for the treatment of burn wound
Infections. Gene Ther 2005;12:1494-502.
85. Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S. Host defense
peptides and their antimicrobial-immunomodulatory duality. Immunobiology
2011;216:322-33.
86. Yeung AT, Gellatly SL, Hancock RE. Multifunctional cationic host defence
peptides and their clinical applications. Cell Mol Life Sci 2011;68:2161-76.